Intertek Pharmaceutical Services at ICSE 2010

Article

The Intertek Team will be launching some important new and expanded services at ICSE 2010. New services include GMP Microbiology Services and expanded capabilities for Extractable / Leachable studies.

ICSE Booth: 4BIO34
pharma-europe@intertek.com

The Intertek Team will be launching some important new and expanded services at ICSE 2010. New services include GMP Microbiology Services and expanded capabilities for Extractable / Leachable studies.

Breaking news at the Intertek centre of excellence for biopharmaceutical characterization in Manchester brings a significant increase in LC-MS/MS characterization capabilities for protein and antibody therapeutics contributing to our existing protein characterization suite catering for all requirements of the ICHQ6B Guidelines. Capabilities include peptide mapping, amino acid analysis, amino acid sequencing, PTM and glycosylation analysis and more. Intertek are happy to announce a FREE SEMINAR on the 23rd of Nov in Manchester focusing on the requirements of ICH Q6B and the analytics to achieve compliance. Please contact us to request further information or drop by the ICSE stand to find out more.

Come meet the team to find out about our latest facility expansion which has seen our GMP facility in Athlone Ireland significantly increase its laboratory footprint and find out about our new GLP facility in Basel, Switzerland. Our team is ready to answer any questions you may have about or GLP bioanalytical, GMP pharmaceutical analysis and GMP microbiology capabilities. We look forward to meeting you in Paris!

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content